Innovator Taro Pharmaceutical Industries (announced in a press release Here ) that it has filed a patent infringement lawsuit against generic players Synerx Pharma, DPT Labs and Karalex Pharma in the United States District Court for New Jersey for infringement of following Orange Book listed patent:
US7560445 (Assignee: Taro Pharma; Expiry: Feb 1, 2027): The patent covers a topical pharmaceutical composition comprising malathion, said malathion having a purity of greater than about 98.5%
Malathion 0.5% topical Lotion (Ovider) is used for the treatment of patients infected with pediculus humanus capitis (head lice and their ova) of the scalp hair
1 comment:
Malathion Registration Review Docket; Reopening of Comment Period until October 5th, 2009
EPA issued a notice in the Federal Register of June 24, 2009, concerning the availability of multiple registration review dockets for public comment, including malathion. This document reopens the comment period for the malathion registration review docket, which closed on August 24, 2009, until October 5, 2009.
DATES: Comments, identified by docket identification (ID) number EPA-HQ-OPP-2009-0317, must be received on or before October 5, 2009.
FOR FURTHER INFORMATION CONTACT: Eric Miederhoff, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: (703) 347-8028; e-mail address: miederhoff.eric@epa.gov.
Malathion information was found at http://www.CyberRegs.com
Post a Comment